Options Trading

On January 10, I was holding a covered call on Bristol-Myers Squibb (BMY), a dividend-paying stock, with the expectation that it would expire worthless. With an hour left before the market closed,…

On January 6, I executed a simple yet effective options strategy: I purchased 101 shares of Bristol-Myers Squibb (ticker: BMY) at $56.13 per share and simultaneously sold a single in-the-money (ITM)…

Embarking on a new challenge is always exciting, especially when it comes to something as dynamic and rewarding as options trading. After years of honing my skills with options, I’ve decided to take…

This week has been exceptional for my stock portfolio, and I'm excited to share the progress. The approach I’ve adopted is heavily inspired by the successful TerraMatris Crypto Hedge Fund, which has…

After holding a long ETH perpetual contract combined with covered calls for about four weeks, I managed to close the position with a modest gain of around $40. While it wasn't a significant profit,…

Selling cash-secured put options can be a lucrative strategy for generating income and acquiring stocks at a discount. However, it's not without its drawbacks. Here are 10 reasons why selling cash-…

I usually aim to get my Friday options expiry articles out on time, but this week was a bit different. My Friday was packed, not only in the options market but also in life outside of trading. After…

Lately, I've been diving deep into the strategy of fully cash-secured puts without using margin—a method we've also been employing at TerraMatris Crypto Hedge Fund and our CryptoRentalYield Fund.…

Today, I executed a bull put spread on Bristol-Myers Squibb (BMY), a stock I've been trading since 2020/2021. BMY is a global biopharmaceutical company that focuses on discovering, developing, and…

As an investor and DIY enthusiast, I recently embarked on a journey to slowly acquire shares in Stanley Black & Decker (SWK), leveraging my fascination with their renowned DeWalt power tools.The…